Note Blood-brain barrier penetration, 2,039 molecules - binary classification

Note BACE-1 inhibition (Alzheimer's target), 1,513 compounds

Note Clinical trial toxicity and FDA approval status, 1,477 drugs

Note 12 nuclear-receptor and stress-response assays, 7,831 compounds

Note Marketed-drug side effects by MedDRA organ class, 1,427 drugs

Note Aqueous solubility regression, 1,128 compounds

Note Hydration free energy regression, 642 molecules

Note logD at pH 7.4, 4,200 compounds - core ADMET endpoint

Note 41,127 compounds screened for HIV replication inhibition

Note US medical licensing exam questions, 11,451 items

Note Medical entrance exam questions, 193,155 items